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Abstract  
Acute myeloid leukemia (AML) involves a block in terminal differentiation of 
the myeloid lineage and uncontrolled proliferation of a progenitor state. Using 
phorbol myristate acetate it is possible to overcome this block in THP-1 cells (a 
M5-AML containing the MLL-MLLT3 fusion), resulting in differentiation to an 
adherent monocytic phenotype. As part of FANTOM4 we used microarrays to 
identify 23 microRNAs that are regulated by PMA. We identify four PMA 
induced microRNAs (mir-155, mir-222, mir-424 and mir-503) that when over-
expressed cause cell cycle arrest and partial differentiation and when used in 
combination induce additional changes not seen by any individual microRNA. 
We further characterise these pro-differentiative microRNAs and show that mir-
155 and mir-222 induce G2 arrest and apoptosis respectively. We find mir-424 
and mir-503 are derived from a polycistronic precursor mir-424-503 that is 
under repression by the MLL-MLLT3 leukemogenic fusion. Both of these 
microRNAs directly target cell cycle regulators and induce G1 cell cycle arrest 
when over-expressed in THP-1. We also find that the pro-differentiative mir-424 
and mir-503 down-regulate the anti-differentiative mir-9 by targeting a site in its 
primary transcript. Our study highlights the combinatorial effects of multiple 
microRNAs within cellular systems. 
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Introduction  
The FANTOM4 (Functional ANnoTation Of Mammals) project used a combination 
of deep sequencing, microarrays, bioinformatic predictions and siRNA perturbations 
to map a network of mammalian transcription factors and their targets (1). For this 
project we studied monocytic differentiation of the M5 acute myeloid leukemia 
(AML) cell line THP-1 (2). This cell line contains the MLL-MLLT3 leukemogenic 
gene fusion (3) and displays a monoblastic phenotype, however upon phorbol 
myristate acetate (PMA) treatment it differentiates into an adherent monocytic 
phenotype (4),  closely approximating monoblast to monocyte differentiation. 
 
In this parallel study we monitored the expression dynamics of microRNAs after 
PMA treatment and sought to identify those that might promote differentiation. 
MicroRNAs are short 21-22 nucleotide RNA molecules which cause translational 
repression and degradation of multiple messenger RNAs by binding target sequences 
in their 3’ UTRs (5). Multiple microRNAs are implicated in differentiation of cell 
lineages including skeletal muscle, adipocytes and neurons (6-8) and in mammals, the 
microRNA sub-system is essential for embryonic development. Dicer is required for 
differentiation of embryonic stem cells (9), Dicer (-/-) knockouts are embryonic lethal 
(10) and Ago2 (-/-) knockouts suffer severe haematopoietic defects (11). In addition 
several microRNAs are deleted or amplified in cancer and have been implicated as 
tumour suppressors (12, 13) or oncogenic (14, 15).  
 
In this study we find multiple microRNAs are induced upon PMA treatment and that 
four of these can promote both partial monocytic differentiation and cell cycle arrest 
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in over-expression experiments. Our data suggests a model whereby multiple 
microRNAs are induced in conjunction with various transcription factors to co-
operatively promote differentiation and inhibit cellular proliferation at multiple points 
in the cell cycle. 
 
Materials and methods    
The details of this section are available online as Supplementary Information.    
Results 
Multiple microRNAs are induced during PMA induced THP-1 differentiation.  
The expression patterns of microRNAs during PMA induced THP-1 differentiation 
were determined using Agilent microRNA arrays on biological triplicate time-
courses. The expression profile for each microRNA after PMA treatment is available 
through the FANTOM4 EdgeExpress Database (16). Between undifferentiated (0h) 
and differentiated (96h) states we identified 21 microRNAs that were up-regulated 
and 2 that were down-regulated with average expression changes of at least 3 fold 
(Table 1). Of the up-regulated microRNAs, several have been previously implicated 
in haematopoiesis including mir-424 which promotes monocytopoiesis (17), mir-221, 
mir-222 and mir-24 which inhibit eryrthopoiesis (18, 19) and mir-155 which promotes 
B-cell proliferation and depletes myeloid and erythroid hematopoietic stem cell 
populations (20, 21). Of the two down-regulated microRNAs, mir-210 promotes 
osteoblast differentiation (22) and mir-9 blocks B-cell differentiation by targeting 
PRDM1 (23). We note that although detected in THP1 the mir-17-92 polycistron 
previously reported to prevent monocytic differentiation by repression of AML1 (24) 
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is not significantly down-regulated suggesting our cells are at a different stage of 
differentiation.  
 
Deep-sequencing of small RNAs from one of the three THP-1 biological replicates 
time-courses (25) confirmed the differential expression of microRNAs detected by the 
arrays. Fold change estimates by the two technologies varied (eg. mir-221 was 
induced 5.7 fold on the arrays but 10.9 fold by sequencing) but repression or 
induction was consistent. We also estimated microRNA abundances from the 
sequencing and found mir-221 the most abundant inducible microRNA in THP-1 
accounting for 11% of all tags at 96h (106251 tags per million). 
 
MicroRNAs 155, 222, 424 and 503 partially promote monocytic differentiation 
A set of 11 PMA regulated microRNAs (10 induced and 1 repressed) with a wide 
range of abundances (eg. mir-146b – 23 tpm, mir-221 – 106251 tpm) were selected 
for further studies. Synthetic microRNA precursors were transfected into 
undifferentiated THP-1 cells and the effect on gene expression measured after 48hrs 
using Illumina Sentrix6v2 whole genome microarrays. Significant expression changes 
were determined by B-statistic comparison (26) against the effect of a scrambled 
negative control duplex RNA (B-statistic ≥ 2.5 and fold change ≥ 2) (Supplementary 
table 1). Lists of up and down-regulated mRNAs were then compared to PMA 
regulated mRNAs identified in the FANTOM4 data (1) to identify microRNAs that 
promote differentiation. Expression changes induced by the microRNA over-
expressions could be then split into PMA-like (pro-differentiative) changes, unrelated 
changes and anti-PMA-like (anti-differentiative) changes. 
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MicroRNAs were considered pro-differentiative if 1) there were more PMA-like 
changes than anti-PMA-like changes (at least 1.5x) and 2) for the given microRNA 
the fraction of all changes that were PMA-like was greater than the average fraction 
plus one standard deviation (Supplementary Table 2). None of the microRNAs 
completely reiterated the expression changes observed with PMA, and no 
morphological differences were observed, however using the above criteria mir-155, 
mir-222, mir-424 and mir-503 induced expression changes suggesting partial 
differentiation including induction of known markers of differentiation ITGAL 
(Cd11a), ITGB7 and ENG (Cd105) by mir-155 and ITGAL, ITGB2 and CSF1R by 
mir-503 (Supplementary Fig. 1). Mir-155 and mir-503 had the greatest ratio of PMA-
like to anti-PMA-like changes (2.9x) and mir-503 also had the greatest number of 
PMA-like changes in total (75 down, 35 up). As a comparison the additional negative 
control microRNA (mir-142 – expressed in THP-1 but not regulated by PMA) failed 
to induce pro-differentiative expression changes and had a differentiation ratio of 
0.3x. 
 
The combined effect of the four microRNAs was then tested by co-over-expressing 
mir-155, mir-222, mir-424 and mir-503 in equimolar amounts in THP-1 for 48hrs. 
The mixture induced 69 pro-differentiative changes, 39 of which were not observed in 
any of the four individual pre-miRNA transfections (including modest induction of 
the key monocytic marker CD14 - supplementary figure 2). One quarter of all changes 
induced by the mixture were PMA like and the ratio of PMA-like to anti-PMA-like 
changes was 6.3x, far larger than observed for any of the individual miRNA 
transfections (Supplementary Table 2). Together this suggests that the mixture more 
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closely mimics the PMA induced expression changes by reducing the non-specific 
and anti-PMA-like changes and increasing the PMA-like changes. 
 
Finally we also identify mir-9 as an anti-differentiative miRNA using this analysis. 
36% of the genes down-regulated by mir-9 over-expression are normally up-regulated 
with PMA and 26% of all expression changes for mir-9 were anti-differentiative 
suggesting it helps maintain the undifferentiated monoblast state similar to its role in 
blocking B-cell differentiation (23).  
 
mir-424-503 is a polycistronic microRNA cluster that promotes differentiation 
and G1 arrest of the cell cycle.  
Gene ontology analysis (27) of genes affected by the pro-differentiative microRNAs 
revealed that both mir-424 and mir-503 down-regulate genes annotated as cell-cycle 
regulators (Table 2 and supplementary table 3). This is consistent with a report that 
mir-424 over-expression can induce G1 arrest of the cell cycle (28). We confirmed 
this in THP-1 cells using flow cytometry and also show that mir-503 induces G1 
arrest to similar levels as mir-424 (Fig. 1). In addition we find mir-222 induces a G2 
accumulation, while mir-155 was depleted for G2 with accumulation of a sub-G1 
population, suggesting apoptosis.  
 
Examination of the mir-424 and mir-503 loci finds they are separated by 383 bases on 
the genome and likely to be derived from the same primary transcript. We confirm 
this using RT-PCR (Fig 2A & B, Supplementary Fig.4). A further five microRNAs 
(mir-542-5p, mir-542-3p, mir-450a, mir-450b-5p, mir-450b-3p) that are within 7KB 
of mir-424-503 may also be generated from the same primary transcript, and two of 
 - 8 - 
these (mir-542-5p and mir-542-3p) are also induced. However the deep sequencing 
results show these are present at much lower levels than mir-424 and mir-503 (see 
Table 1).  
 
Finally we observe that the mir-424-503 polycistronic microRNAs have related seed 
sequences, thus they share target genes explaining why both can induce partial 
differentiation and cell cycle arrest (Fig. 2C). The array analysis shows overlapping 
but distinct sets of targets for both mir-424 and mir-503, and despite similarity to mir-
15/16 members neither induced apoptosis (29). This arrangement of polycistronic 
microRNAs with shared seed sequences has been reported for mir-15a-mir-16-1 (29, 
30), and mir-17-92 (14), and may be a common architecture. 
 
mir-424 and mir-503 directly target multiple cell cycle regulators. 
Mir-424 has been previously shown to target the cell cycle regulators CCNE1, 
CCND1, CCND3 and CDK6 (28, 31) and all of these are down-regulated at the 
mRNA level in our over-expression experiments (0.77, 0.84, 0.69 and 0.85 fold 
respectively). To identify the likely direct targets of mir-503 and the other 
microRNAs identified in this study we compared publicly available microRNA target 
predictions (both EIMMO and TargetScan (32, 33)) with the lists of genes down-
regulated in the microRNA over-expression experiments (for full lists of putative 
targets see supplementary table 4 and also supplementary Fig. 3). 
  
A combined set of predicted mir-424 and mir-503 targets with roles in cell cycle were 
then tested using luciferase reporter assays with mir-424, mir-503 and mir-9 co-
transfection (Fig. 3). The known mir-424 targets CCNE1 and CCND1 were the 
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second and third most affected targets of mir-424 and were also affected by mir-503, 
while PRDM1 and ETS1 which lack predicted mir-424/503 sites were the least 
affected (Fig. 3A). Conversely PRDM1 was the most affected construct in the mir-9 
transfection, while WEE1 and CDC14A lacking mir-9 target sites were the least 
affected. 
 
Using BCL6 and POU2F2 constructs as thresholds for non-specific down-regulation 
(these both lack mir-424/503 sites) we find the following, mir-424 targets ANLN, 
CCNE1, CCND1, WEE1, ATF6, KIF23, CHEK1, CDC25A, CDC14A and CCNF 
while mir-503 targets CDC14A, ANLN, CCND1, ATF6, EIF2C1, CDC25A, CHEK1, 
CCNE1, CCNE2, WEE1, CCNF and CDKN1A. We note that seven of these targets 
appear in both lists, however they are affected to different levels eg. CDC14A was the 
most affected target of mir-503 but tenth strongest by mir-424, reflective of the 
different affinities of the mir-424 and mir-503 sequences.  
 
The pro-differentiative mir-424-503 polycistron also targets the primary 
transcript of the anti-differentiative mir-9-3  
Mentioned previously, mir-9 is down-regulated during differentiation and when over-
expressed induces anti-differentiative gene expression changes. The mature 
microRNA can be generated from three possible locations, mir-9-1, 9-2 and 9-3, 
however mir-9-3 is the most likely copy regulated in THP-1 differentiation as both 
Illumina microarray signal (Fig. 4A) and Cap Analysis of Gene Expression signal 
(data not shown) for the primary transcript is down-regulated with PMA. 
Surprisingly, over-expression of either mir-424 or mir-503 also down-regulated mir-
9-3 (Fig. 4A) and upon examining the primary transcript sequence we identified a 
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potential mir-424-503 target sequence (Supplementary figure 5). When tested in a 
luciferase assay the sequence was targeted by both mir-424 and mir-503 (underlined 
Fig. 3). This suggests that at least in vitro the pro-differentiative microRNAs mir-424 
and mir-503 may directly down-regulate the anti-differentiative mir-9. 
 
Regulation of the mir-424-mir-503 polycistron 
A review of public expression data for the primary transcript (MGC16121) finds that 
it is serum inducible in fibroblasts (34) and up-regulated during normal monocyte to 
macrophage maturation (35) (Gene Expression Omnibus (GEO) (36) entries: 
GDS1568 / 8259, 16661, 40711 / MGC16121 and GDS2430 / 227488_at, 229784_at / 
MGC16121). In addition, from the FANTOM4 knockdown panel of 52 myeloid 
transcription factors (1) we find knock-down of the MLL-MLLT3 leukemogenic 
fusion of THP-1 induced mir-424-503 (Fig. 4B). Knockdown of MLL-MLLT3 has 
previously been shown to induce differentiation and cessation of cellular proliferation 
(37, 38). Our analysis suggests that repression of mir-424-503 by MLL-MLLT3 may 
help maintain proliferation and prevent cell cycle arrest and differentiation by mir-424 
and mir-503, two putative tumour suppressor microRNAs of the mir-15/16 family 
(29, 39).  
Discussion 
Twenty three microRNAs were identified that are dynamically expressed during 
monocytic differentiation of the THP-1 acute myeloid leukemia cell line. Four of 
these induce partial differentiation and cell cycle arrest when over-expressed. Three 
have been previously implicated in haematopoietic differentiation (17, 19, 21) 
however this is the first report implicating mir-503 and suggesting they co-operate to 
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promote monocytic differentiation. Mir-424 was previously reported as regulated by 
SPI1(PU.1) and inducing monocytic differentiation by targeting NFIA (17), however 
in THP-1, NFIA is not expressed and SPI1 knockdown has no effect on mir-424 
expression suggesting other targets and regulators are involved. We show that mir-
424 and mir-503 are produced as a polycistronic message which is repressed by MLL-
MLLT3 and that both induce G1 arrest by targeting an overlapping set of cell cycle 
regulators. We also show both target the primary transcript of mir-9 an anti-
differentiative microRNA. This is the first report to our knowledge of a set of pro-
differentiative microRNAs targeting the primary transcript of an anti-differentiative 
microRNA. 
 
For mir-155 and mir-222 we observed apoptosis and G2 cell cycle arrest respectively. 
From the array data and target site predictions we identify several targets that could 
explain the respective phenotypes (see supplementary table 4). We hypothesize that 
apoptosis by mir-155 occurs by targeting anti-apoptotic factors (similar to BCL2 
targeting by mir-15/16 (29)) and predict RPS6KA3, SGK3, RHEB and KRAS as 
likely targets (40-43) three of which have supporting protein level evidence as targets 
(RPS6KA3, RHEB and KRAS) (44, 45). Apoptosis by mir-155 has not been 
previously reported but may explain the selective depletion of myeloid and erythroid 
hematopoetic stem cell populations in preference for B-cell proliferation (21), and 
also explain the fraction of apoptotic THP-1 cells observed with PMA treatment (46). 
 
We also predict the G2 accumulation of THP-1 induced by mir-222 is via targeting of 
CDKN1B, RB1 and SKP1A by mir-222. Knock-down of RB1 and SKP1A can 
increase G2 populations (47, 48) and CDKN1B is a validated target (49, 50). We note 
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that in different cell lines mir-222 can induce either an S-phase or G1-accumulation 
(51, 52). This highlights that the effect of mir-222, like mir-155 and perhaps most 
microRNAs is context specific. The phenotype in any given cell type will depend on 
the expression levels of microRNA targets and all the other components with which 
they are networked. 
 
The interconnected nature of these components is best demonstrated by the 
observations regarding the four microRNAs. All four were shown to induce cell cycle 
phenotypes and for mir-424 and mir-503 we confirmed down-regulation of direct 
targets by luciferase assay, however these microRNAs also induced significant 
numbers of genes. For example 57 of the 209 genes induced by the four microRNA 
mix are also induced by PMA. These must be indirect targets, which are induced 
through down-regulation of anti-differentiative components of the monoblast state, 
such as pri-mir-9-3 (Fig. 5).  
 
Finally THP-1 differentiation involves the co-ordinated up-regulation of transcription 
factor activities involved in the differentiated monocyte phenotype and down-
regulation of factors primarily involved in cell cycle (1). Artificial siRNA knockdown 
of these naturally down-regulated factors or over-expression of the four microRNAs 
individually can promote partial differentiation however none are sufficient to 
completely reiterate differentiation in THP1. This is most likely because state 
transition (from one ‘transcriptional basin’ (1) to another) requires co-ordination of 
multiple components including transcription factors, microRNAs and cytokines, and 
perturbation of a single component is insufficient to perturb the system from one 
stable basin state to another. To test this in part we have shown that co-over-
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expression of all four microRNAs promotes a more specific PMA like response than 
over-expression of any individual microRNA, and it would be interesting to combine 
this further with knock down of specific transcription factors such as MYB and MLL-
MLLT3. The data we have presented here has been generated using the THP-1 cell 
line containing the MLL-MLLT3 fusion. It will be important now to test the role of 
these microRNAs in primary AML samples and cell lines with other known genetic 
legions and compare them with normal monoblasts to see whether over-expression of 
these microRNAs could be used as a potential differentiative therapy. 
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Figure legends 
Figure 1 - DNA content analysis of microRNA transfections by flow cytometry 
DNA content was assessed using propidium iodide staining 48hr post transfection. 
Note: mir-424 and mir-503 induced a G1 accumulation, mir-222 induced a G2 
accumulation and mir-155 depleted G2 and accumulated a sub-G1 population. 
Untreated THP-1 cells and THP-1 transfected with scrambled RNA duplex (NegCon) 
are included as controls. 
Figure 2 – mir-424 and mir-503 are from a polycistronic cluster and their seed 
regions match the mir-16 family of microRNAs. 
A) Genomic organisation of hsa-mir-424-503, ESTs, mature microRNAs, TSS and 
RT-PCR amplicons are shown, B) RT-PCR confirmation of the precursor RNA 
(gDNA = genomic DNA positive control, RT(-) negative control RT reaction minus 
reverse transcriptase. Amplicon descriptions – 1: mir-424-mir-503, 2 & 3: TSS1 and 
TSS2 to mir-503, 4 & 5: TSS1 and TSS2 to mir-424, C) Multiple alignment of mir-
424 and mir-503 to mir-16 family.  NOTE: qRT-PCR also confirmed a transcript 
spanning mir-424 and mir-503 (Supplementary Fig. 4). 
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Figure 3 – Luciferase reporter assays 
Relative luciferase expression levels of 3’ UTR reporter constructs transfected with 
synthetic precursors of A) mir-424, B) mir-503 and C) mir-9, compared to a 
scrambled negative control. Previously reported targets CCND1, CCNE1 and PRDM1 
are marked with an asterix *. Predicted targets are shown in grey, predicted non-
targets lacking sites are shown in black. Confirmed targets are shown by grey boxes. 
Figure 4 – Primary transcript expression summaries 
A) Expression of the mir-9-3 primary transcript by Illumina microarray (probeID 
7560564). The transcript is down-regulated by PMA and also by mir-424 and mir-503 
over-expression (B-statistics of 8.56 and 14.20 respectively).  B) Expression of the 
putative mir-424-mir-503 primary transcript by Illumina microarray (probeID 
6270392). The transcript is induced with PMA and MLL-MLLT3 knock-down (B-
statistic of 0.51). Note: knock-down of a previously reported regulator SPI1(PU.1) 
had no effect on expression (17). 
Figure 5 - Proposed microRNA regulated quiescence in monocytic 
differentiation 
The PMA induced microRNAs mir-155, mir-222, mir-424 and mir-503 indirectly 
promote differentiation and directly down-regulate proliferation by targeting multiple 
cell cycle. White nodes are pro-differentiative nodes, grey nodes are anti-
differentiative. Direct and indirect edges are shown as solid and dashed lines 
respectively.  
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Tables 
Table 1 - microRNAs induced or repressed >= 3 fold in THP-1 after 96hours 
PMA induced differentiation. 
Dynamically 
regulated 
microRNAs 
microRNA 
array 
Small RNA sequencing 
fold 
change 
fold 
change 
max cpm 
Induced 
miR-221 5.7 10.9 106251 
miR-24 3.2 2.2 65581 
miR-222 3.3 6.4 55722 
miR-124 39.3 44 30058 
miR-22 14.7 7.6 18316 
miR-29b 5.3 3.4 10154 
miR-29a 5.2 2 6087 
miR-503 6.8 8.3 4099 
miR-424 5.1 1.9 1971 
miR-155 3 1.3 1445 
miR-30a-5p 4.3 1.9 568 
miR-132 12.3 11.5 294 
miR-542-3p 4.8 2.6 172 
miR-137 17.3 9.5 153 
miR-151 10.2 1.8 105 
miR-133a 7.7 ND 70 
miR-542-5p 4.3 ND 67 
miR-146b 5.6 ND 23 
miR-193b 3.7 ND 19 
miR-133b 12 ND < 1 
miR-146a 17 ND ND 
 - 24 - 
    
Repressed 
miR-210 0.3 0.5 22801 
miR-9 0.3 0.04 17871 
 
microRNAs are ranked by maximum counts per million in the small RNA sequencing 
which is described in (25).  
 
 
Table 2 - Top 5 gene ontologies enriched in genes down-regulated with over-
expression of mir-424 and mir-503 
microRNA p-value term ontology 
mir-424 3.86E-11 gene expression GO:0010467 
 3.39E-08 RNA metabolic process GO:0016070 
 2.39E-07 nucleobase, nucleoside, nucleotide 
and nucleic acid metabolic process 
GO:0006139 
 2.39E-07 cell cycle phase GO:0016070 
  3.12E-06 cell cycle GO:0006139 
    
mir-503 1.40E-05 cell division GO:0051301 
 1.84E-04 cell cycle GO:0007049 
 1.84E-04 cell cycle phase GO:0022403 
 1.84E-04 M phase GO:0000279 
  2.34E-04 mitosis GO:0007067 
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Supplementary Materials and methods 
Cell culture and RNA extraction 
Human monoblast leukemia THP-1 cells were maintained in RPMI1640 medium (Invitrogen, 
Carlsbad, CA, USA), 1mM sodium pyruvate, 10 mM HEPES supplemented with 0.001 % (v/v) 2-
mercaptoethanol, 10 µg/ml Penicillin/ Streptomycin (Invitrogen) and 10% fetal bovine serum at 
37°C in a 5% CO2 and 95% O2 atmosphere. RNA was purified for expression analysis by Qiagen 
RNeasy columns, Takara FastPure RNA Kit or TRIzol. RNA quality was checked by Nanodrop and 
Bioanalyser. For the pre-microRNA over-expression experiments Total RNA was extracted 48h 
after transfection, using the FastPure RNA kit (TAKARA BIO, Ohtsu, Shiga, Japan) in accordance 
with the manufacturer’s instructions. 
 
pre-miRNA overexpression experiments 
THP-1 cells were seeded in 6 cm dishes at a density of 1 × 10
6
 cells/dish for transfection. 
Transfection was performed with 1.6 µg/ml (final concentration) of Lipofectamine 2000 
(Invitrogen) and 20 µM (final concentration) of pre-miRNA (Ambion or Nihon-shinyaku) by 
reverse transfection protocol in accordance with the manufacturer’s instructions. For the co-
over-expression experiment 5uM for mir-155, mir-222, mir-424 and mir-503 was used. 
 
Agilent miRNA microarrays 
RNA purification, sample preparation and hybridization to Agilent Human miRNA Microarrays 
(Agilent) was performed essentially as described in the Agilent Technical Manual using 100 ng 
total RNA. Microarrays were scanned with Agilent’s DNA Microarray Scanner and expressed 
numerically with Agilent Feature Extraction Software. The biological triplicate data was ‘per 
chip’ normalized in GeneSpring GX (Agilent). Each measurement was divided by the 90
th
 
percentile of all measurements in that sample. Note: due to the small number of probes on the 
arrays (534), per chip normalization is generally not recommended however an alternative such 
as spike in controls was not available, therefore, we trialed normalization to the median and 
other deciles. The 90
th
 percentile gave us the most consistent profiles between the biological 
replicate time-courses.   
 
Deep Sequencing data analysis 
Library generation and sequence mapping is described previously (1). All sequences shorter 
than 18 nucleotides were discarded. The remaining sequences were aligned against all mature 
and star sequences in mirbase (release 12) using nexalign (T.Lassman manuscript in 
preparation). The raw expression for each miRNA sequence was determined by counting the 
number of sequences mapping to genome loci overlapping the genomic location of the mature 
miRNA. Normalized expression values were derived by dividing each raw expression with the 
total expression of miRNAs at each time-point and multiplying by one million. 
 
Illumina microarray analysis 
Sample amplification and hybridisation 
RNA (500 ng) was amplified using the Illumina TotalPrep RNA Amplification Kit, according to 
manufacturer’s instructions. cRNA was hybridized to Illumina Human Sentrix-6 bead chips 
Ver.2, according to standard Illumina protocols (http://www.illumina.com). 
 
Raw data curation and normalization of Illumina microarray 
Chips scans were processed using Illumina BeadScan and BeadStudio software packages and 
summarized data was generated in BeadStudio (version 3.1). The summarized data from 
BeadStudio was imported into R/BioConductor using the readBead function from the 
BeadExplorer package (http://bioconductor.org/packages/1.9/bioc/html/BeadExplorer.html). 
Background adjustment and quantile normalization (2) was performed using algorithms within 
the affymetrix package (3) (function: bg.adjust and normalize.quantiles). The normalized data 
was exported out off R/BioConductor with write.beadData function. 
 
Normalisation and statistical analysis of Illumina microarray data 
All microarray experiments were conducted in biological triplicate. A gene was considered 
detected if the average detection score (p-value) of the three replicates was less than 0.01. 
Quantile normalization and B-statistic calculations were carried out using the lumi and limma 
packages of Bioconductor in the R statistical language (4-6). For differential gene expression 
during the timecourse and between siRNAs, pre-miRNAs and negative control transfections we 
required a B-statistic ≥ 2.5, fold change ≥ 2 and the gene had to be detected in one of the 
conditions (average detection score ≤ 0.01). 
 
RT-PCR confirmation of the hsa-mir-424, hsa-mir-503 precursor 
Primers were designed overlapping the mature hsa-mir-424 and hsa-mir-503 sequences and 
internal to the transcription start sites described in (7). The primers for amplicons 1 to 5 are the 
following. amplicon 1 (chrX:133508023-133508403) used primer1: GGG ATA CAG CAG CAA TTC 
ATG T, and primer4: TTA CCC TGG CAG CGG AAA CAA TAC, amplicon 2 (chrX:133508023-
133508586) used primer2: CAC CTG CAG CTC CTG GAA ATC AAA and primer4, amplicon 3 
(chrX:133508023-133508641) used primer4 and primer3: CGT TGT TCC AAG ATT CAT CCT CAG 
GG, amplicon 4 (chrX:133508337-133508586) used primer2 and primer5: GGT ATA GCA GCG 
CCT CAC GTT T and amplicon 5 (chrX:133508336-133508641) used primer3 and primer5. 
 
cDNA was made from a pool of THP-1 RNAs across the PMA time-course (0～96hr 10point Mix). 
Templates tested by PCR were 1) positive control Genomic DNA 100ng/100ul, 2) negative 
control RT(-) total RNA 12.5ng/25ul, and 3) test RT(+) total RNA 12.5ng/25ul RNA).   
 
MicroRNA target predictions 
MicroRNA target predictions were downloaded from http://www.targetscan.org/ (version 4.2 
April 2008), and http://www.mirz.unibas.ch/ElMMo2/ (release 2 January 2008). 
 
Luciferase reporter constructs to test sites in the 3’UTR of predicted targets 
Luciferase reporter constructs were generated from 3 fragment fusion PCR as described 
previously (8). The fragments consisted of 1) a CMV promoter driving a destabilised luciferase 
(the PCR template for this was generated by subcloning the destabilised luciferase from 
pGL4.12_luc2CP (Promega) into pMIR-REPORT (Ambion)), 2) A fragment containing the 
predicted miRNA target sites in 3’UTRs of candidate target mRNAs to be tested (PCR primers 
are given in supplementary table 3). 3) an SV40 late poly-adenylation signal amplified from pG5 
vector (Promega). 
 
Samples for the assay were constructed by using PCR. The followings are PCR primers used; 
target-specific forward primer, 5’-GAA GGA GCC GCC ACC ATG-3’ followed by approximately 20-
base 5’-end target sequence; target-specific reverse primer, 5’-CAA TTT CAC ACA GGA AAC TCA-
3’ followed by approximately 20-base 3’-end target sequence; PMIR_CMV_F, 5’-GGG TCA TTA 
GTT CAT AGC CCA-3’; Luc2CP_Luc_R, 5’-CAT GGT GGC GGC TCC TTC TTA GAC GTT GAT CCT GGC 
GCT-3’; FSV40LPAS02, 5’-GTT TCC TGT GTG AAA TTG TTA TCC GCT GCA GAC ATG ATA AGA TAC 
ATT G-3’; RSV40LPAS01, 5’-AGC AAG TTC AGC CTG GTT AAG ATC CTT ATC GAT TTT ACC AC-3’; 
PMIR_CMV_Nested_F, 5’-GGG AGG AGA AGC ATG AAT TCA AGG-3’; LGT10L, 5’-AGC AAG TTC 
AGC CTG GTT AAG-3’; FPCMV5, 5’-GCC ATG TTG GCA TTG ATT ATT GAC-3’; (The sequences in 
bold type are complementary to the common tag sequences of the target-specific forward and 
reverse primers, respectively). 
 Each target sequence was amplified with the designed target-specific forward and 
reverse primers. The fragment for the CMV promoter and the Luc2CP gene was PCR-amplified 
from pMIR_Luc2CP vector using the primer sets PMIR_CMV_F and Luc2CP_Luc_R. The fragment 
for the SV40 late poly-adenylation signal (SV40LPAS) was PCR-amplified from pG5 vector 
(Promega) using the primer sets FSV40LPAS02 and RSV40LPAS01. Overlapping PCR was carried 
out to connect the target fragments with the CMV_Luc2CP-fragment and the SV40LPAS 
fragment using the primer pair PMIR_CMV_Nested_F and LGT10L. PCR conditions were based 
on those in our previous reports.  
 
The fragment for the CMV promoter, Renilla luciferase gene and SV40LPAS was also PCR-
amplified from pRL-CMV using the primer sets FPCMV5 and RSV40LPAS01. All PCR products 
were checked by agarose gel electrophoresis after the amplification. 
 
CR Primers were designed flanking miRNA target sites in 3’UTRs of candidate target mRNAs 
(supplementary table 1). A CMV-luciferase PCR fragment Fusion PCR was used to generate 
constructs.  
 
  
MicroRNA target validation by luciferase assay 
miRNA target reporter assays were carried out in 96-well assay plates and were repeated three 
times. Each target construct (0.2 µl), the Renilla luciferase fragment (0.2 µl) and pre-miRNA (2 
pmol) were diluted to 95 µl with Opti-MEM (Invitrogen) followed by mixing 50 µl of 2% 
Lipofectamine2000 (Invitrogen). After 20 min incubation at room temperature, the suspended 
Hela cells (88,000 cells/55 µl) were mixed for transfection (total 200 µl). After 48h of 
incubation, fire fly and Renilla luciferase reporters were sequentially measured using the Dual-
Glo Luciferase Assay system (Promega) according to the manufacture’s protocol. The reporter 
activity for fire fly luciferase was normalized by that for Renilla luciferase. 
 Flow cytometry 
48 hours after pre-miRNA transfection, cells were harvested and fixed in 70% ince cold ethanol. 
Fixed cells were washed in PBS and then DNA stained (2.5 μg/ml propidium iodide, and 0.5 
mg/ml RNase A in PBS). Flow cytometry analysis was done using a FACS Calibur (Becton 
Dickinson, Franklin, NJ, USA) instrument following the manufacturer’s recommended protocol. 
Data were collected and processed using the FlowJo FACS analysis software (Tree Star, Inc., 
Ashland, OR, USA). 
 
Data deposition 
All expression data has been deposited at the Center for Information Biology gene EXpression 
database (CIBEX (9)). Accession numbers for the Illumina mRNA measurements are CBX46 (PMA 
time-course), CBX45 (pre-miRNA over-expression), and CBX47 (52 transcription factor 
knockdowns). The accession number for the Agilent miRNA array experiment is CBX49. The 
small RNA sequences of Taft et al. (1) are deposited at DDBJ (Accessions: AIAAF0000001 - 
AIAAF0055261, AIAAG0000001 - AIAAG0013956, AIAAH0000001 - AIAAH0046376, 
AIAAI0000001 - AIAAI0087752, AIAAJ0000001 - AIAAJ0100819, AIAAP0000001 - AIAAP0061402, 
AIAAQ0000001 - AIAAQ0033032, AIAAR0000001 - AIAAR0049623, AIAAS0000001 - 
AIAAS0055455, AIAAT0000001 - AIAAT0061351). 
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Supplementary legends 
Supplementary figures: 
Supplementary Figure 1 - Monocytic markers induced with microRNA 
over-expression  
The mRNA expression profiles of monocytic markers induced with PMA and upon over-
expression of the four pro-differentiative microRNAs (hsa-mir-424, hsa-mir-503, hsa-mir-222, 
hsa-mir-155). Illumina array expression is shown relative to 0h for the time-course and relative 
to the scrambled negative control transfection for the microRNA over-expression experiments. 
The published PMA time course data was extracted from FANTOM4 EdgeExpressDB (22).  
 
Supplementary Figure 2 – Combinatorial effect of four miRNA co-
transfection  
A) Modest induction of CD14 by the four miRNA mix.  
B) Pro-differentiative changes induced by individual miRNAs and from the four way mix. 
 
Supplementary Figure 3 - The mRNAs of predicted microRNA targets are 
down-regulated  
Histograms showing the median fold change in mRNA levels of cells transfected with synthetic 
pre-microRNAs relative to negative control transfections for predicted microRNA targets (red) or 
all genes (black), and for varying strengths of predictions (blue bars). Both TargetScan (1) and 
EIMMO (2) predictions are shown. Bin 0 corresponds to genes with prediction strengths 
between >0 and <0.1, Bin 0.1 to values between >0.1 and <0.2 etc. Bin 1 is only used for 
EIMMO (2) predictions with values greater than 1. TS_all and TS_cons correspond to all 
TargetScan (1) predictions versus conserved only predictions. Prediction strength for 
TargetScan corresponds to context-score as defined by the TS paper. Note mir-142 (the 
microRNA that does not change levels during the differentiation has the smallest change).  
 
Supplementary Figure 4 – qRT confirmation of mir-424-mir-503 
polycistron  
qRT-PCR confirmation of the transcript spanning mir424 and mir503. NOTE: RT- samples are 
not detected (ct=40), indicating no DNA contamination. 
 
Supplementary Figure 5 – mir-424-mir-503 target site in pri-mir-9-3  
Location of a potential mir-424-mir-503 target site in the primary transcript of mir-9-3. Note: A 
luciferase reporter construct containing this UTR was significantly down-regulated by both mir-
424 and mir-503 over-expression.  
 
 
Supplementary tables: 
Supplementary table 1 – Perturbed genes 
Combined list of genes significantly perturbed in any of the microRNA over-expression experiments. 
 
Supplementary Table 2 - Pro-differentiative effects of pre-microRNA 
transfections 
microRNAs that induce changes in mRNA expression similar to those seen in PMA treated THP-1 cells are 
shown in gold, and microRNAs that repress changes seen with PMA are shown in green.  The label diff 
corresponds to the fraction of changes that match the PMA differentiative response (ie sum of changes 
that upregulate genes that are also upregulated with PMA plus the changes that downregulated genes 
that are also down-regulated with PMA). The label undiff is the opposite (ie. The microRNA induced 
expression changes in the opposite direction to PMA induced expression changes). 
 
Supplementary table 3 – Gene ontology enrichment 
Gene ontology enrichments for genes up or down-regulated in THP-1 miRNA over-expression 
experiments. 
 
Supplementary table 4 – predicted direct targets down-regulated at the 
RNA level 
A list of predicted targets of all microRNAs tested that are supported by mRNA down-regulation (at least 
0.75x that of control).  
 
Supplementary table 5 – PCR primers used for 3’UTR luciferase 
constructs 
Fold change of targets tested by luciferase assay. PCR primers and amplicons sizes are included. 
  
 
 
 
Supplementary Table 2 - Pro-differentiative effects of pre-microRNA transfections 
microRNAs that induce changes in mRNA expression similar to those seen in PMA treated THP-1 cells are 
shown in gold, and microRNAs that repress changes seen with PMA are shown in green.  The label diff 
corresponds to the fraction of changes that match the PMA differentiative response (ie sum of changes 
that upregulate genes that are also upregulated with PMA plus the changes that downregulated genes 
that are also down-regulated with PMA). The label undiff is the opposite (ie. The microRNA induced 
expression changes in the opposite direction to PMA induced expression changes). 
 
Micro-
RNA 
Down-regulated with microRNA Up-regulated with microRNA ALL changes   
diff/ 
undiff 
Number 
of 
probes 
Down 
in 
PMA  
Up 
in 
PMA 
Fraction 
down in 
PMA 
Fraction 
up in 
PMA 
Number 
of 
probes 
Up 
in 
PMA 
Down 
in 
PMA  
Fraction 
up in 
PMA 
Fraction 
down in 
PMA 
Number 
of 
probes 
Fraction 
matches 
PMA 
(diff) 
Fraction 
opposite 
to PMA 
(undiff) 
mir-155 178 19 12 10.7% 6.7% 340 65 17 19.1% 5.0% 518 16.2% 5.6% 2.9 
mir-503 735 75 15 10.2% 2.0% 244 35 23 14.3% 9.4% 979 11.2% 3.9% 2.9 
mir-424 88 4 11 4.5% 12.5% 121 31 7 25.6% 5.8% 209 16.7% 8.6% 1.9 
mir-222 109 15 12 13.8% 11.0% 96 12 5 12.5% 5.2% 205 13.2% 8.3% 1.6 
mir-132 148 15 23 10.1% 15.5% 150 12 5 8.0% 3.3% 298 9.1% 9.4% 1.0 
mir-221 113 9 19 8.0% 16.8% 69 5 6 7.2% 8.7% 182 7.7% 13.7% 0.6 
mir-142 376 21 92 5.6% 24.5% 217 10 21 4.6% 9.7% 593 5.2% 19.1% 0.3 
mir-22 132 6 41 4.5% 31.1% 65 3 6 4.6% 9.2% 197 4.6% 23.9% 0.2 
mir-29a 232 9 57 3.9% 24.6% 116 6 23 5.2% 19.8% 348 4.3% 23.0% 0.2 
mir-9 145 5 52 3.4% 35.9% 119 6 16 5.0% 13.4% 264 4.2% 25.8% 0.2 
mir-29b 227 7 63 3.1% 27.8% 107 6 19 5.6% 17.8% 334 3.9% 24.6% 0.2 
mir-
146b 173 3 51 1.7% 29.5% 64 3 14 4.7% 21.9% 237 2.5% 27.4% 0.1 
mix 69 12 6 17.4% 8.7% 209 57 5 27.3% 2.4% 278 24.8% 4.0% 6.3 
    median 5.1% 20.6%       6.4% 9.3%   6.5% 16.4%   
  std_dev 3.8% 10.6%    6.9% 6.1%  5.0% 8.7%  
  Threshold 8.9% 31.2%    13.3% 15.5%  11.5% 25.1%  
Supplementary Figure 1 - Monocytic markers induced with microRNA over-
expression
The mRNA expression profiles of monocytic markers induced with PMA and upon over-expression of 
the four pro-differentiative microRNAs (hsa-mir-424, hsa-mir-503, hsa-mir-222, hsa-mir-155). Illumina 
array expression is shown relative to 0h for the time-course and relative to the scrambled negative 
control transfection for the microRNA over-expression experiments. The published PMA time course 
data was extracted from FANTOM4 EdgeExpressDB (22). 
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Supplementary Figure 2 – Combinatorial effect of four miRNA co-transfection
A) Modest induction of CD14 by the four miRNA mix.
B) Pro-differentiative changes induced by individual miRNAs and from the four way mix.
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Supplementary Figure 3 - The mRNAs of predicted microRNA targets are 
down-regulated 
Histograms showing the median fold change in mRNA levels of cells transfected with synthetic 
pre-microRNAs relative to negative control transfections for predicted microRNA targets (red) or 
all genes (black), and for varying strengths of predictions (blue bars). Both TargetScan (1) and 
EIMMO (2) predictions are shown. Bin 0 corresponds to genes with prediction strengths between 
>0 and <0.1, Bin 0.1 to values between >0.1 and <0.2 etc. Bin 1 is only used for EIMMO (2) 
predictions with values greater than 1. TS_all and TS_cons correspond to all TargetScan (1)  
predictions versus conserved only predictions. Prediction strength for TargetScan corresponds to 
context-score as defined by the TS paper. Note mir-142 (the microRNA that does not change 
levels during the differentiation has the smallest change). 
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Supplementary Figure 4 – qRT confirmation of mir-424-mir-503 polycistron
qRT-PCR confirmation of the transcript spanning mir424 and mir503. NOTE: RT(-) samples are not 
detected (ct=40), indicating no DNA contamination.
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Primer_1+4 Primer_2+4 Primer_3+4 Primer_2+5 Primer_3+5
Human Genomic DNA
0.1/well
rep1 32.7
34.2
rep1 39.6
38.2
rep1 36.6
37.6
rep1 32.3
33.0
rep1 33.2
32.9rep2 34.3 rep2 37.9 rep2 36.9 rep2 33.4 rep2 31.7
rep3 35.5 rep3 37.0 rep3 39.4 rep3 33.2 rep3 33.7
rep1 37.4 rep1 37.5 rep1 38.3 rep1 31.7 rep1 31.9THP1_timecourse_pool_RT(+)
total RNA 2.5ng/well 36.9 38.6 38.5 31.5 31.8rep2 35.2 rep2 40.0 rep2 39.1 rep2 31.4 rep2 31.3rep3 38.2 rep3 38.4 rep3 38.2 rep3 31.5 rep3 32.2
THP1_timecourse_pool _RT(-)
total RNA 2.5ng/well
rep1 40.0
40.0
rep1 40.0
40.0
rep1 40.0
40.0
rep1 40.0
40.0
rep1 40.0
40.0rep2 40.0 rep2 40.0 rep2 40.0 rep2 40.0 rep2 40.0
rep3 40.0 rep3 40.0 rep3 40.0 rep3 40.0 rep3 40.0
Amplicons: FWD REV size Genomic span
1: mir424_TO_mir503 primer1 primer4 381 chrX:133508023-133508403
2: TSS+100_TO_mir503 primer2 primer4 564 chrX:133508023-133508586
3: TSS2_TO_mir503 primer3 primer4 619 chrX:133508023-133508641
4: TSS+100_TO_mir424 primer2 primer5 250 chrX:133508337-133508586
5: TSS2_TO_mir424 primer3 primer5 305 chrX:133508336-133508641
primer1 GGGATACAGCAGCAATTCATGT
primer2 CACCTGCAGCTCCTGGAAATCAAA
primer3 CGTTGTTCCAAGATTCATCCTCAGGG
primer4 TTACCCTGGCAGCGGAAACAATAC
primer5 GGTATAGCAGCGCCTCACGTTT
Supplementary Figure 5 – mir-424-mir-503 target site in pri-mir-9-3
Location of a potential mir-424-mir-503 target site in the primary transcript of mir-9-3. Note: A 
luciferase reporter construct containing this UTR was significantly down-regulated by both mir-424 and 
mir-503 over-expression.
5'UGCUCACAGCAGGCAGGGCCUAGACCCGGGAGCCAUGCUGCUGUGCUGU3'  (position in AK125292, approx 1264)
. |    .     | .||||||.
3'gacgucuugacaagggcgacgau5' (mir-503)
. . |   ||||||||
3'aaguuuuguacuuaacgacgac5' (mir-424)
Note: Watson-crick base pairing marked with |
G-U base pairing is marked with .
